Home » Stocks » Abbott Laboratories » Financials » Balance Sheet

Abbott Laboratories (ABT)

Stock Price: $92.23 USD 0.59 (0.64%)
Updated Jul 2, 2020 4:02 PM EDT - Market closed

Abbott Laboratories Balance Sheet (Annual)

The table below shows the annual balance sheet for Abbott Laboratories stock for the past 25 years.

Numbers in millions USD. Fiscal year is January-December.
Year2019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995
Cash3,8604,0869,61018,7756,1254,4608,09815,1748,0975,4519,9325,0802,4565212,8941,226995704657914608315240110281
Short-Term Investments280--------1,872--36485262.4183329126256.1624311595.8352.8212.8834.50
Cash & Equivalents4,1404,0869,61018,7756,1254,4608,09815,1748,0977,3249,9325,0802,8211,3732,9562,0591,2869667141,157723411293123316
Cash Growth1.32%-57.48%-48.81%206.53%37.33%-44.92%-46.63%87.39%10.56%-26.26%95.53%80.08%105.38%-53.54%43.57%60.05%33.15%35.4%-38.31%59.92%75.96%40.51%137.69%-61.01%-
Receivables5,4255,1825,2493,2483,4183,5863,9867,6137,6847,1846,5425,4664,9474,2313,5773,6963,3132,9272,8132,1792,0561,9561,7841,7091,563
Inventory4,3163,7963,6012,4342,5992,6432,6933,7933,2843,1893,2652,7762,9512,8062,5422,6202,7382,4412,2121,7411,4951,4131,2811,2381,111
Other Current Assets1,7861,5681,6872,3192,0132,8674,4704,7434,7034,6213,5753,7213,3242,8712,3112,3592,2762,1212,6812,2992,1451,8101,7181,4111,237
Total Current Assets15,66714,63220,14726,77614,15513,55619,24731,32323,76922,31823,31417,04314,04311,28211,38610,7349,6148,4558,4197,3766,4205,5905,0764,4814,227
Property, Plant & Equipment8,0387,5637,6075,7055,7305,9355,9058,0637,8747,9717,6197,2197,5186,9466,0036,0086,2825,8285,5524,8174,7704,7434,5724,4624,250
Long-Term Investments8838978832,9474,0412291192743783021,1331,0741,1251,2301341464061,657647638955968764666423
Goodwill and Intangibles40,22042,19645,49312,22215,20016,26515,50724,36225,69528,08219,49215,13815,84915,8539,96110,8578,5397,6527,2941,5551,5751,3501,112980156
Other Long-Term Assets3,0791,8852,1205,0162,1215,2222,1753,2132,5611,9021,0231,9451,1788671,6571,0231,1970.001,384897752610578538358
Total Long-Term Assets52,22052,54156,10325,89027,09227,65123,70635,91236,50838,25629,26825,37725,67124,89617,75518,03316,42515,13714,8777,9078,0517,6707,0266,6455,186
Total Assets67,88767,17376,25052,66641,24741,20742,95367,23560,27760,57452,58242,41939,71436,17829,14128,76726,03923,59323,29615,28314,47113,26012,10211,1269,413
Accounts Payable3,2522,9752,4021,1781,0811,0641,0261,7971,7211,5361,2811,3511,2201,1761,0331,0541,0789951,5251,3561,2271,0571,002923756
Current Debt1,4782077141,3253,1304,4373,1732,3913,3756,3955,1902,7322,7265,4012,0621,9932,5372,1492,9534798961,7591,7821,3841,050
Other Current Liabilities6,1335,8305,7964,1574,9754,9665,3089,09210,3849,3326,5797,5085,1585,3744,3213,7783,3483,1923,4482,4622,3942,1492,2542,0371,985
Total Current Liabilities10,8639,0128,9126,6609,18610,4679,50713,28015,48017,26213,04911,5929,10311,9517,4166,8266,9646,3367,9274,2984,5174,9665,0384,3443,790
Long-term Debt16,66119,35927,21020,6815,8713,3933,38818,08512,04012,52411,2668,7139,4887,0104,5724,7883,4524,2744,3351,0761,3371,340938933435
Other Long-Term Liabilities9,0628,0809,0304,6084,8645,7084,7919,0578,2318,0235,0784,5953,2993,1632,7392,8282,5512,3181,9751,3381,1901,2011,0901,029790
Total Long-Term Liabilities25,72327,43936,24025,28910,7359,1018,17927,14220,27120,54616,34513,30912,78710,1737,3107,6166,0046,5926,3102,4152,5272,5402,0281,9621,225
Total Liabilities36,58636,45145,15231,94919,92119,56817,68640,42235,75137,80929,39424,90121,89022,12414,72614,44212,96712,92814,2376,7127,0437,5067,0656,3055,016
Total Debt18,13919,56627,92422,0069,0017,8306,56120,47615,41518,91816,45611,44512,21412,4116,6346,7815,9906,4237,2891,5562,2333,0992,7202,3171,485
Debt Growth-7.29%-29.93%26.89%144.48%14.96%19.34%-67.96%32.84%-18.52%14.96%43.78%-6.29%-1.59%87.09%-2.17%13.2%-6.74%-11.88%368.49%-30.33%-27.94%13.95%17.39%56%-
Common Stock13,91913,74813,1822,4152,2273,8185,3006,2566,2164,9164,9914,8574,9364,0963,2652,9692,7482,5832,3731,9451,6591,238911636526
Retained Earnings25,84724,56023,97825,56525,75722,87421,97924,15120,90719,21617,34313,82510,8069,56910,40510,0339,6918,6017,2817,2306,1744,7434,3554,1843,927
Comprehensive Income-8,465-7,586-6,062-7,263-6,658-5,053-2,012-3,594-2,597-1,367854-1,1642,0823907451,324633-520-595-603-405-228-230--55.65
Shareholders Equity31,30130,72231,09820,71721,32621,63925,26726,81324,52622,76523,18717,51917,82414,05414,41514,32613,07210,6659,0598,5717,4285,7545,0364,8204,397
Total Liabilities and Equity67,88767,17376,25052,66641,24741,20742,95367,23560,27760,57452,58242,41939,71436,17829,14128,76726,03923,59323,29615,28314,47113,26012,10211,1269,413
Net Cash / Debt-13,999-15,480-18,314-3,231-2,876-3,3701,537-5,302-7,317-11,594-6,524-6,366-9,393-11,037-3,677-4,722-4,703-5,457-6,575-399-1,510-2,688-2,427-2,194-1,169
Net Cash / Debt Growth-9.57%-15.47%466.82%12.34%-14.66%---27.54%-36.89%77.72%2.49%-32.23%-14.9%200.14%-22.12%0.39%-13.8%-17.02%1547.51%-73.57%-43.83%10.75%10.64%87.58%-
Net Cash Per Share-7.92-8.81-10.53-2.19-1.92-2.220.99-3.37-4.70-7.50-4.22-4.12-6.09-7.21-2.37-3.03-3.01-3.50-4.24-0.26-0.98-1.75-1.56-1.40-0.74